Convergent hub pathways targeted by IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells: molecular mechanisms and therapeutic implications

Zhang et al., Frontiers in Immunology, doi:10.3389/fimmu.2026.1781447, Mar 2026
Review synthesizing cross-virus evidence for convergent pathogenic mechanisms of IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells (AEC2s), with therapeutic implications for COVID-19.
Zhang et al., 11 Mar 2026, China, peer-reviewed, 8 authors. Contact: 2461530536@qq.com.
Abstract: OPEN ACCESS EDITED BY Luciana Padua Tavares, Harvard Medical School, United States REVIEWED BY Aline Haas de Mello, University of Texas Medical Branch at Galveston, United States Rushikesh Deshpande, University of Pittsburgh, United States *CORRESPONDENCE Yuanyuan Xu fl oryxyy@163.com Kaixuan Zhang [2461530536@qq.com](mailto:2461530536@qq.com) RECEIVED 05 January 2026 REVISED 23 February 2026 ACCEPTED 25 February 2026 PUBLISHED 11 March 2026 CITATION Zhang K, Zhu S, Zhang M, Hu H, Qin S, Li H, Zhao P and Xu Y (2026) Convergent hub pathways targeted by IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells: molecular mechanisms and therapeutic implications. Front. Immunol. 17:1781447. doi: 10.3389/fimmu.2026.1781447 COPYRIGHT © 2026 Zhang, Zhu, Zhang, Hu, Qin, Li, Zhao and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. [Convergent hub pathways targeted by IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells: molecular mechanisms and therapeutic implications](https://www.frontiersin.org/articles/10.3389/fimmu.2026.1781447/full) Kaixuan Zhang*, Sudi Zhu, Mengyu Zhang, Henggui Hu, Shuguo Qin, Huihui Li, Pingping Zhao and Yuanyuan Xu * Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital, Suzhou, China Type II alveolar epithelial cells (AEC2s) maintain surfactant homeostasis, support distal-lung repair, and contribute to antiviral innate defense. In fl uenza A virus (IAV), SARS-CoV-2, and respiratory syncytial virus (RSV) use distinct entry receptors, yet severe disease is repeatedly marked by AEC2 dysfunction, alveolar barrier failure, and dysregulated in fl ammation. We synthesize crossvirus evidence for convergence on a small set of host hubs: innate sensing and interferon signaling, mitochondria-centered immunometabolism and oxidative stress, post-translational signaling modules, barrier and surfactant programs, and regulated cell-death checkpoints. We summarize structural and posttranslational mechanisms by which viral proteins disrupt pattern recognition receptor (PRR) -mitochondrial antiviral signaling protein (MAVS) signaling, couple mitochondrial injury to weakened antiviral responses, and bias epithelial fate toward in fl ammatory lytic injury. Where AEC2-speci fi c evidence is incomplete, especially for integrated PANoptosis-like programs, we label these elements as working models and highlight validation needs. We compare model systems used to study AEC2 infection, including ALI cultures, organoids, lung-onchip platforms, and single-cell or network analyses. Finally, we discuss hostdirected therapeutic opportunities along the cascade, separating near-term approaches from longer-term platform strategies such as targeted protein degradation and targeted nanodelivery, and noting constraints in distal-lung delivery, onset kinetics, and safety. This AEC2-centered convergence framework supports mechanism-driven interpretation of severe viral pneumonia and guides broader-spectrum intervention concepts. KEYWORDS type II alveolar epithelial cells, SARS-CoV-2, signal transduction,..
DOI record: { "DOI": "10.3389/fimmu.2026.1781447", "ISSN": [ "1664-3224" ], "URL": "http://dx.doi.org/10.3389/fimmu.2026.1781447", "abstract": "<jats:p>Type II alveolar epithelial cells (AEC2s) maintain surfactant homeostasis, support distal-lung repair, and contribute to antiviral innate defense. Influenza A virus (IAV), SARS-CoV-2, and respiratory syncytial virus (RSV) use distinct entry receptors, yet severe disease is repeatedly marked by AEC2 dysfunction, alveolar barrier failure, and dysregulated inflammation. We synthesize cross-virus evidence for convergence on a small set of host hubs: innate sensing and interferon signaling, mitochondria-centered immunometabolism and oxidative stress, post-translational signaling modules, barrier and surfactant programs, and regulated cell-death checkpoints. We summarize structural and post-translational mechanisms by which viral proteins disrupt pattern recognition receptor (PRR)–mitochondrial antiviral signaling protein (MAVS) signaling, couple mitochondrial injury to weakened antiviral responses, and bias epithelial fate toward inflammatory lytic injury. Where AEC2-specific evidence is incomplete, especially for integrated PANoptosis-like programs, we label these elements as working models and highlight validation needs. We compare model systems used to study AEC2 infection, including ALI cultures, organoids, lung-on-chip platforms, and single-cell or network analyses. Finally, we discuss host-directed therapeutic opportunities along the cascade, separating near-term approaches from longer-term platform strategies such as targeted protein degradation and targeted nanodelivery, and noting constraints in distal-lung delivery, onset kinetics, and safety. This AEC2-centered convergence framework supports mechanism-driven interpretation of severe viral pneumonia and guides broader-spectrum intervention concepts.</jats:p>", "alternative-id": [ "10.3389/fimmu.2026.1781447" ], "article-number": "1781447", "author": [ { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Zhang", "given": "Kaixuan", "sequence": "first" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Zhu", "given": "Sudi", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Zhang", "given": "Mengyu", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Hu", "given": "Henggui", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Qin", "given": "Shuguo", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Li", "given": "Huihui", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Zhao", "given": "Pingping", "sequence": "additional" }, { "affiliation": [ { "name": "Department of Clinical Laboratory, Wanbei Coal Electric Group General Hospital", "place": [ "Suzhou, China" ] } ], "family": "Xu", "given": "Yuanyuan", "sequence": "additional" } ], "container-title": "Frontiers in Immunology", "container-title-short": "Front. Immunol.", "content-domain": { "crossmark-restriction": true, "domain": [ "frontiersin.org" ] }, "created": { "date-parts": [ [ 2026, 3, 11 ] ], "date-time": "2026-03-11T06:52:31Z", "timestamp": 1773211951000 }, "deposited": { "date-parts": [ [ 2026, 3, 11 ] ], "date-time": "2026-03-11T06:52:34Z", "timestamp": 1773211954000 }, "indexed": { "date-parts": [ [ 2026, 3, 11 ] ], "date-time": "2026-03-11T22:40:07Z", "timestamp": 1773268807219, "version": "3.50.1" }, "is-referenced-by-count": 0, "issued": { "date-parts": [ [ 2026, 3, 11 ] ] }, "license": [ { "URL": "https://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2026, 3, 11 ] ], "date-time": "2026-03-11T00:00:00Z", "timestamp": 1773187200000 } } ], "link": [ { "URL": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1781447/full", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "1965", "original-title": [], "prefix": "10.3389", "published": { "date-parts": [ [ 2026, 3, 11 ] ] }, "published-online": { "date-parts": [ [ 2026, 3, 11 ] ] }, "publisher": "Frontiers Media SA", "reference": [ { "DOI": "10.1056/NEJMoa2001017", "article-title": "A novel coronavirus from patients with pneumonia in China, 2019", "author": "Zhu", "doi-asserted-by": "publisher", "journal-title": "N Engl J Med", "key": "B1", "volume": "382", "year": "2020" }, { "DOI": "10.1016/s0140-6736(22)00478-0", "article-title": "Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis", "author": "Li", "doi-asserted-by": "publisher", "journal-title": "Lancet", "key": "B2", "volume": "399", "year": "2022" }, { "DOI": "10.1016/s1473-3099(23)00630-8", "article-title": "Changes in the global hospitalisation burden of respiratory syncytial virus in young children during the COVID-19 pandemic: a systematic analysis", "author": "Cong", "doi-asserted-by": "publisher", "journal-title": "Lancet Infect Dis", "key": "B3", "volume": "24", "year": "2024" }, { "DOI": "10.1016/s0140-6736(20)30183-5", "article-title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", "author": "Huang", "doi-asserted-by": "publisher", "first-page": "497", "journal-title": "Lancet", "key": "B4", "volume": "395", "year": "2020" }, { "DOI": "10.1126/science.abd4570", "article-title": "Inborn errors of type I IFN immunity in patients with life-threatening COVID-19", "author": "Zhang", "doi-asserted-by": "publisher", "first-page": "eabd4570", "journal-title": "Science", "key": "B5", "volume": "370", "year": "2020" }, { "DOI": "10.1371/journal.pmed.1003987", "article-title": "Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis", "author": "Buitrago-Garcia", "doi-asserted-by": "publisher", "first-page": "e1003987", "journal-title": "PLoS Med", "key": "B6", "volume": "19", "year": "2022" }, { "DOI": "10.1001/jamainternmed.2024.7452", "article-title": "Severity and long-term mortality of COVID-19, influenza, and respiratory syncytial virus", "author": "Bajema", "doi-asserted-by": "publisher", "journal-title": "JAMA Intern Med", "key": "B7", "volume": "185", "year": "2025" }, { "DOI": "10.1126/scitranslmed.adk8623", "article-title": "Hypoxia-inducible factor 2 regulates alveolar regeneration after repetitive injury in three-dimensional cellular and in vivo models", "author": "McCall", "doi-asserted-by": "publisher", "first-page": "eadk8623", "journal-title": "Sci Transl Med", "key": "B8", "volume": "17", "year": "2025" }, { "DOI": "10.1165/rcmb.2024-0372TR", "article-title": "From epithelium to therapy: transitional cells in lung fibrosis", "author": "Shin", "doi-asserted-by": "publisher", "journal-title": "Am J Respir Cell Mol Biol", "key": "B9", "volume": "72", "year": "2025" }, { "DOI": "10.1152/physrev.00056.2024", "article-title": "Immunological and regenerative properties of lung stem cells", "author": "Hao", "doi-asserted-by": "publisher", "first-page": "485", "journal-title": "Physiol Rev", "key": "B10", "volume": "106", "year": "2026" }, { "DOI": "10.1016/j.cell.2020.02.052", "article-title": "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor", "author": "Hoffmann", "doi-asserted-by": "publisher", "first-page": "271", "journal-title": "Cell", "key": "B11", "volume": "181", "year": "2020" }, { "DOI": "10.1038/s41586-020-2180-5", "article-title": "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor", "author": "Lan", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B12", "volume": "581", "year": "2020" }, { "DOI": "10.1038/s41580-021-00418-x", "article-title": "Mechanisms of SARS-CoV-2 entry into cells", "author": "Jackson", "doi-asserted-by": "publisher", "first-page": "3", "journal-title": "Nat Rev Mol Cell Biol", "key": "B13", "volume": "23", "year": "2022" }, { "DOI": "10.1073/pnas.2111400119", "article-title": "SARS-CoV-2 spreads through cell-to-cell transmission", "author": "Zeng", "doi-asserted-by": "publisher", "first-page": "e2111400119", "journal-title": "Proc Natl Acad Sci U S A", "key": "B14", "volume": "119", "year": "2022" }, { "DOI": "10.1126/science.abb2762", "article-title": "Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2", "author": "Yan", "doi-asserted-by": "publisher", "journal-title": "Science", "key": "B15", "volume": "367", "year": "2020" }, { "DOI": "10.1080/07391102.2024.2322629", "article-title": "Efficiency of membrane fusion inhibitors on different hemagglutinin subtypes: insight from a molecular dynamics simulation perspective", "author": "Nunthaboot", "doi-asserted-by": "publisher", "journal-title": "J Biomol Struct Dyn", "key": "B16", "volume": "43", "year": "2025" }, { "DOI": "10.1038/s41579-020-00468-6", "article-title": "Coronavirus biology and replication: implications for SARS-CoV-2", "author": "V’Kovski", "doi-asserted-by": "publisher", "journal-title": "Nat Rev Microbiol", "key": "B17", "volume": "19", "year": "2021" }, { "DOI": "10.1038/s41467-024-50162-x", "article-title": "Assembly of respiratory syncytial virus matrix protein lattice and its coordination with fusion glycoprotein trimers", "author": "Sibert", "doi-asserted-by": "publisher", "first-page": "5923", "journal-title": "Nat Commun", "key": "B18", "volume": "15", "year": "2024" }, { "DOI": "10.1038/s41392-024-01858-5", "article-title": "Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein", "author": "Yang", "doi-asserted-by": "publisher", "first-page": "144", "journal-title": "Signal Transduct Target Ther", "key": "B19", "volume": "9", "year": "2024" }, { "DOI": "10.1016/j.cell.2020.04.035", "article-title": "SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues", "author": "Ziegler", "doi-asserted-by": "publisher", "first-page": "1016", "journal-title": "Cell", "key": "B20", "volume": "181", "year": "2020" }, { "DOI": "10.1074/jbc.REV120.013309", "article-title": "Adaptation of influenza viruses to human airway receptors", "author": "Thompson", "doi-asserted-by": "publisher", "first-page": "100017", "journal-title": "J Biol Chem", "key": "B21", "volume": "296", "year": "2021" }, { "DOI": "10.1016/j.imbio.2019.02.006", "article-title": "Full-length human surfactant protein A inhibits influenza A virus infection of A549 lung epithelial cells: A recombinant form containing neck and lectin domains promotes infectivity", "author": "Al-Qahtani", "doi-asserted-by": "publisher", "journal-title": "Immunobiology", "key": "B22", "volume": "224", "year": "2019" }, { "DOI": "10.1016/j.ijbiomac.2023.126527", "article-title": "Helicase-independent function of RIG-I against murine gammaherpesvirus 68 via blocking the nuclear translocation of viral proteins", "author": "Xu", "doi-asserted-by": "publisher", "journal-title": "Int J Biol Macromol", "key": "B23", "volume": "250", "year": "2023" }, { "DOI": "10.1038/nature05732", "article-title": "TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity", "author": "Gack", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B24", "volume": "446", "year": "2007" }, { "DOI": "10.1128/jvi.00004-25", "article-title": "The ELF3-TRIM22-MAVS signaling axis regulates type I interferon and antiviral responses", "author": "Zhao", "doi-asserted-by": "publisher", "first-page": "e0000425", "journal-title": "J Virol", "key": "B25", "volume": "99", "year": "2025" }, { "DOI": "10.3389/fimmu.2025.1549766", "article-title": "Human papillomavirus E1 proteins inhibit RIG-I/MDA5-MAVS, TLR3-TRIF, cGAS-STING, and JAK-STAT signaling pathways to evade innate antiviral immunity", "author": "Li", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B26", "volume": "16", "year": "2025" }, { "DOI": "10.1159/000527535", "article-title": "Sirtuin3 alleviated influenza A virus-induced mitochondrial oxidative stress and inflammation in lung epithelial cells via regulating poly (ADP-ribose) polymerase 1 activity", "author": "Yuan", "doi-asserted-by": "publisher", "journal-title": "Int Arch Allergy Immunol", "key": "B27", "volume": "184", "year": "2023" }, { "DOI": "10.1128/JVI.00985-20", "article-title": "Type I and type III interferons restrict SARS-CoV-2 infection of human airway epithelial cultures", "author": "Vanderheiden", "doi-asserted-by": "publisher", "journal-title": "J Virol", "key": "B28", "volume": "94", "year": "2020" }, { "DOI": "10.1016/j.celrep.2020.107549", "article-title": "Cellular importin-α3 expression dynamics in the lung regulate antiviral response pathways against influenza A virus infection", "author": "Thiele", "doi-asserted-by": "publisher", "journal-title": "Cell Rep", "key": "B29", "volume": "31", "year": "2020" }, { "DOI": "10.3390/v13050905", "article-title": "Dual R108K and G189D mutations in the NS1 protein of A/H1N1 influenza virus counteract host innate immune responses", "author": "Huang", "doi-asserted-by": "publisher", "journal-title": "Viruses", "key": "B30", "volume": "13", "year": "2021" }, { "DOI": "10.1038/s41586-021-04352-y", "article-title": "Evolution of enhanced innate immune evasion by SARS-CoV-2", "author": "Thorne", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B31", "volume": "602", "year": "2022" }, { "DOI": "10.1038/s41579-022-00839-1", "article-title": "Innate immune evasion strategies of SARS-CoV-2", "author": "Minkoff", "doi-asserted-by": "publisher", "journal-title": "Nat Rev Microbiol", "key": "B32", "volume": "21", "year": "2023" }, { "DOI": "10.1016/j.mib.2024.102466", "article-title": "Differences and similarities between innate immune evasion strategies of human coronaviruses", "author": "Hoenigsperger", "doi-asserted-by": "publisher", "journal-title": "Curr Opin Microbiol", "key": "B33", "volume": "79", "year": "2024" }, { "DOI": "10.1016/j.antiviral.2024.105944", "article-title": "Characterization and noncovalent inhibition of the K63-deubiquitinase activity of SARS-cov-2 PLpro", "author": "Liu", "doi-asserted-by": "publisher", "journal-title": "Antiviral Res", "key": "B34", "volume": "228", "year": "2024" }, { "DOI": "10.1002/pro.70156", "article-title": "Identification, validation, and characterization of approved and investigational drugs interfering with the SARS-CoV-2 endoribonuclease Nsp15", "author": "Chatziefthymiou", "doi-asserted-by": "publisher", "first-page": "e70156", "journal-title": "Protein Sci", "key": "B35", "volume": "34", "year": "2025" }, { "DOI": "10.3389/fimmu.2018.00320", "article-title": "Host immune response to influenza A virus infection", "author": "Chen", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B36", "volume": "9", "year": "2018" }, { "DOI": "10.3389/fimmu.2024.1395809", "article-title": "Respiratory syncytial virus NS1 inhibits anti-viral Interferon-α-induced JAK/STAT signaling, by limiting the nuclear translocation of STAT1", "author": "Efstathiou", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B37", "volume": "15", "year": "2024" }, { "DOI": "10.1016/j.virol.2015.03.045", "article-title": "Proteomic analysis reveals down-regulation of surfactant protein B in murine type II pneumocytes infected with influenza A virus", "author": "Kebaabetswe", "doi-asserted-by": "publisher", "first-page": "96", "journal-title": "Virology", "key": "B38", "volume": "483", "year": "2015" }, { "DOI": "10.15252/embr.202357137", "article-title": "ORF3c is expressed in SARS-CoV-2-infected cells and inhibits innate sensing by targeting MAVS", "author": "Müller", "doi-asserted-by": "publisher", "first-page": "e57137", "journal-title": "EMBO Rep", "key": "B39", "volume": "24", "year": "2023" }, { "DOI": "10.1146/annurev-virology-092623-102539", "article-title": "Viral modulation of host splicing", "author": "Begg", "doi-asserted-by": "publisher", "journal-title": "Annu Rev Virol", "key": "B40", "volume": "12", "year": "2025" }, { "DOI": "10.3390/ijms262412174", "article-title": "Post-translational modifications in respiratory virus infection: recent insights into the development of in vitro models", "author": "Ben Khlifa", "doi-asserted-by": "publisher", "journal-title": "Int J Mol Sci", "key": "B41", "volume": "26", "year": "2025" }, { "DOI": "10.3389/fcell.2025.1690934", "article-title": "Role of mitochondria-associated membranes (MAMs) in inflammatory signaling: implications for acute lung injury pathogenesis", "author": "Qian", "doi-asserted-by": "publisher", "journal-title": "Front Cell Dev Biol", "key": "B42", "volume": "13", "year": "2025" }, { "DOI": "10.3389/fimmu.2025.1680688", "article-title": "Metabolic regulation of interferon-mediated innate antiviral immunity", "author": "Zhong", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B43", "volume": "16", "year": "2025" }, { "DOI": "10.1128/jvi.00869-24", "article-title": "ISGylation of the SARS-CoV-2 N protein by HERC5 impedes N oligomerization and thereby viral RNA synthesis", "author": "Zhu", "doi-asserted-by": "publisher", "first-page": "e0086924", "journal-title": "J Virol", "key": "B44", "volume": "98", "year": "2024" }, { "DOI": "10.1016/j.cell.2021.05.039", "article-title": "The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination", "author": "Wimmers", "doi-asserted-by": "publisher", "first-page": "3915", "journal-title": "Cell", "key": "B45", "volume": "184", "year": "2021" }, { "DOI": "10.3390/cells12091311", "article-title": "Respiratory syncytial virus matrix protein is sufficient and necessary to remodel host mitochondria in infection", "author": "Hu", "doi-asserted-by": "publisher", "journal-title": "Cells", "key": "B46", "volume": "12", "year": "2023" }, { "DOI": "10.1038/s41586-023-06483-w", "article-title": "Metabolic programs of T cell tissue residency empower tumour immunity", "author": "Reina-Campos", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B47", "volume": "621", "year": "2023" }, { "DOI": "10.1093/ismejo/wrae055", "article-title": "Environment-specific virocell metabolic reprogramming", "author": "Howard-Varona", "doi-asserted-by": "publisher", "journal-title": "Isme J", "key": "B48", "volume": "18", "year": "2024" }, { "DOI": "10.1126/sciadv.adf0115", "article-title": "Acetylcarnitine shuttling links mitochondrial metabolism to histone acetylation and lipogenesis", "author": "Izzo", "doi-asserted-by": "publisher", "first-page": "eadf0115", "journal-title": "Sci Adv", "key": "B49", "volume": "9", "year": "2023" }, { "DOI": "10.1016/j.phrs.2024.107170", "article-title": "SARS-CoV-2 mitochondrial metabolic and epigenomic reprogramming in COVID-19", "author": "Guarnieri", "doi-asserted-by": "publisher", "journal-title": "Pharmacol Res", "key": "B50", "volume": "204", "year": "2024" }, { "DOI": "10.1038/ni.3796", "article-title": "α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming", "author": "Liu", "doi-asserted-by": "publisher", "journal-title": "Nat Immunol", "key": "B51", "volume": "18", "year": "2017" }, { "DOI": "10.1016/j.redox.2025.103765", "article-title": "c-Myc promotes metabolic reprogramming in pulmonary hypertension via the stimulation of glutaminolysis and the reductive tricarboxylic acid cycle", "author": "Yegambaram", "doi-asserted-by": "publisher", "journal-title": "Redox Biol", "key": "B52", "volume": "85", "year": "2025" }, { "DOI": "10.3389/fimmu.2020.01649", "article-title": "Mitochondrial reactive oxygen species: double-edged weapon in host defense and pathological inflammation during infection", "author": "Silwal", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B53", "volume": "11", "year": "2020" }, { "DOI": "10.1038/s41586-023-06017-4", "article-title": "A druggable copper-signalling pathway that drives inflammation", "author": "Solier", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B54", "volume": "617", "year": "2023" }, { "DOI": "10.1111/bph.16271", "article-title": "Supersulfide biology and translational medicine for disease control", "author": "Barayeu", "doi-asserted-by": "publisher", "journal-title": "Br J Pharmacol", "key": "B55", "volume": "183", "year": "2026" }, { "DOI": "10.1073/pnas.0602235103", "article-title": "Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity", "author": "Cummins", "doi-asserted-by": "publisher", "journal-title": "Proc Natl Acad Sci U S A", "key": "B56", "volume": "103", "year": "2006" }, { "DOI": "10.1128/jvi.01783-14", "article-title": "Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis", "author": "Munday", "doi-asserted-by": "publisher", "journal-title": "J Virol", "key": "B57", "volume": "89", "year": "2015" }, { "DOI": "10.1080/21505594.2021.1965829", "article-title": "Mitofusin 2, a key coordinator between mitochondrial dynamics and innate immunity", "author": "Kim", "doi-asserted-by": "publisher", "journal-title": "Virulence", "key": "B58", "volume": "12", "year": "2021" }, { "DOI": "10.1128/mbio.00540-23", "article-title": "The unfolded protein response components IRE1α and XBP1 promote human coronavirus infection", "author": "Oda", "doi-asserted-by": "publisher", "first-page": "e0054023", "journal-title": "mBio", "key": "B59", "volume": "14", "year": "2023" }, { "DOI": "10.1016/j.bbadis.2024.167193", "article-title": "The IRE1α-XBP1 arm of the unfolded protein response is a host factor activated in SARS-CoV-2 infection", "author": "Fernández", "doi-asserted-by": "publisher", "journal-title": "Biochim Biophys Acta Mol Basis Dis", "key": "B60", "volume": "1870", "year": "2024" }, { "DOI": "10.3389/fimmu.2023.1197356", "article-title": "RSV replication modifies the XBP1s binding complex on the IRF1 upstream enhancer to potentiate the mucosal anti-viral response", "author": "Qiao", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B61", "volume": "14", "year": "2023" }, { "DOI": "10.1038/s44318-024-00232-z", "article-title": "ER-phagy restrains inflammatory responses through its receptor UBAC2", "author": "He", "doi-asserted-by": "publisher", "journal-title": "EMBO J", "key": "B62", "volume": "43", "year": "2024" }, { "DOI": "10.1371/journal.ppat.1009890", "article-title": "Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses", "author": "Sasaki", "doi-asserted-by": "publisher", "first-page": "e1009890", "journal-title": "PLoS Pathog", "key": "B63", "volume": "17", "year": "2021" }, { "DOI": "10.1016/j.celrep.2021.109055", "article-title": "SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery", "author": "Mulay", "doi-asserted-by": "publisher", "journal-title": "bioRxiv", "key": "B64", "volume": "35", "year": "2020" }, { "DOI": "10.1038/s41586-020-03148-w", "article-title": "Circuits between infected macrophages and T cells in SARS-CoV-2 pneumonia", "author": "Grant", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B65", "volume": "590", "year": "2021" }, { "DOI": "10.1126/science.abc6027", "article-title": "Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients", "author": "Hadjadj", "doi-asserted-by": "publisher", "journal-title": "Science", "key": "B66", "volume": "369", "year": "2020" }, { "DOI": "10.1186/s13054-022-04062-5", "article-title": "Gasdermin-D activation by SARS-CoV-2 triggers NET and mediate COVID-19 immunopathology", "author": "Silva", "doi-asserted-by": "publisher", "first-page": "206", "journal-title": "Crit Care", "key": "B67", "volume": "26", "year": "2022" }, { "DOI": "10.1128/jvi.01708-25", "article-title": "CircRNA-encoded protein fine-tunes ROS homeostasis and engages conserved JAK-STAT antiviral defenses in Drosophila", "author": "Guo", "doi-asserted-by": "publisher", "first-page": "e0170825", "journal-title": "J Virol", "key": "B68", "volume": "100", "year": "2025" }, { "DOI": "10.1128/mbio.03030-23", "article-title": "Endoplasmic reticulum-associated SARS-CoV-2 ORF3a elicits heightened cytopathic effects despite robust ER-associated degradation", "author": "Zhang", "doi-asserted-by": "publisher", "first-page": "e0303023", "journal-title": "mBio", "key": "B69", "volume": "15", "year": "2024" }, { "DOI": "10.3390/ijms26041575", "article-title": "SARS-CoV-2-ORF-3a mediates apoptosis through mitochondrial dysfunction modulated by the K(+) ion channel", "author": "Qudus", "doi-asserted-by": "publisher", "journal-title": "Int J Mol Sci", "key": "B70", "volume": "26", "year": "2025" }, { "DOI": "10.1038/s41586-024-07265-8", "article-title": "Necroptosis blockade prevents lung injury in severe influenza", "author": "Gautam", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B71", "volume": "628", "year": "2024" }, { "DOI": "10.1016/j.cell.2011.11.031", "article-title": "Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase", "author": "Sun", "doi-asserted-by": "publisher", "journal-title": "Cell", "key": "B72", "volume": "148", "year": "2012" }, { "DOI": "10.1038/nature15514", "article-title": "Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death", "author": "Shi", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B73", "volume": "526", "year": "2015" }, { "DOI": "10.1371/journal.ppat.0010004", "article-title": "Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1", "author": "Zamarin", "doi-asserted-by": "publisher", "first-page": "e4", "journal-title": "PLoS Pathog", "key": "B74", "volume": "1", "year": "2005" }, { "DOI": "10.1007/s12035-024-04107-6", "article-title": "Influenza A virus PB1-F2 induces affective disorder by interfering synaptic plasticity in hippocampal dentate gyrus", "author": "Wang", "doi-asserted-by": "publisher", "journal-title": "Mol Neurobiol", "key": "B75", "volume": "61", "year": "2024" }, { "DOI": "10.1016/j.chom.2009.04.006", "article-title": "Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I", "author": "Gack", "doi-asserted-by": "publisher", "journal-title": "Cell Host Microbe", "key": "B76", "volume": "5", "year": "2009" }, { "DOI": "10.1016/j.virol.2022.01.003", "article-title": "SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway", "author": "Xu", "doi-asserted-by": "publisher", "first-page": "13", "journal-title": "Virology", "key": "B77", "volume": "568", "year": "2022" }, { "DOI": "10.1016/j.molcel.2016.02.023", "article-title": "Co-operative and Hierarchical Binding of c-FLIP and Caspase-8: A Unified Model Defines How c-FLIP Isoforms Differentially Control Cell Fate", "author": "Hughes", "doi-asserted-by": "publisher", "journal-title": "Mol Cell", "key": "B78", "volume": "61", "year": "2016" }, { "DOI": "10.1038/nri2215", "article-title": "How dying cells alert the immune system to danger", "author": "Kono", "doi-asserted-by": "publisher", "journal-title": "Nat Rev Immunol", "key": "B79", "volume": "8", "year": "2008" }, { "DOI": "10.4110/in.2023.23.e26", "article-title": "SARS-CoV-2 infection induces HMGB1 secretion through post-translational modification and PANoptosis", "author": "Kwak", "doi-asserted-by": "publisher", "journal-title": "Immune Netw", "key": "B80", "volume": "23", "year": "2023" }, { "DOI": "10.1016/j.phymed.2023.155159", "article-title": "Helenine blocks NLRP3 activation by disrupting the NEK7-NLRP3 interaction and ameliorates inflammatory diseases", "author": "Fang", "doi-asserted-by": "publisher", "journal-title": "Phytomedicine", "key": "B81", "volume": "122", "year": "2024" }, { "DOI": "10.1007/s11302-024-10062-7", "article-title": "The role of the P2X7 receptor in inactivated SARS-CoV-2-induced lung injury", "author": "Carvalho-Barbosa", "doi-asserted-by": "publisher", "journal-title": "Purinergic Signal", "key": "B82", "volume": "21", "year": "2025" }, { "DOI": "10.1084/jem.20201707", "article-title": "Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients", "author": "Rodrigues", "doi-asserted-by": "publisher", "first-page": "e20201707", "journal-title": "J Exp Med", "key": "B83", "volume": "218", "year": "2021" }, { "DOI": "10.1172/jci.insight.143299", "article-title": "Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19", "author": "Scozzi", "doi-asserted-by": "publisher", "first-page": "e143299", "journal-title": "JCI Insight", "key": "B84", "volume": "6", "year": "2021" }, { "DOI": "10.1038/s41586-022-04802-1", "article-title": "Inflammasome activation in infected macrophages drives COVID-19 pathology", "author": "Sefik", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B85", "volume": "606", "year": "2022" }, { "DOI": "10.1038/nri.2016.153", "article-title": "Programmed cell death and the immune system", "author": "Nagata", "doi-asserted-by": "publisher", "journal-title": "Nat Rev Immunol", "key": "B86", "volume": "17", "year": "2017" }, { "DOI": "10.1016/j.mib.2020.07.012", "article-title": "PANoptosis in microbial infection", "author": "Place", "doi-asserted-by": "publisher", "journal-title": "Curr Opin Microbiol", "key": "B87", "volume": "59", "year": "2021" }, { "DOI": "10.4049/jimmunol.2200508", "article-title": "PANoptosis: A unique innate immune inflammatory cell death modality", "author": "Pandian", "doi-asserted-by": "publisher", "journal-title": "J Immunol", "key": "B88", "volume": "209", "year": "2022" }, { "DOI": "10.1038/s41580-025-00837-0", "article-title": "Mechanistic insights into gasdermin-mediated pyroptosis", "author": "Bai", "doi-asserted-by": "publisher", "journal-title": "Nat Rev Mol Cell Biol", "key": "B89", "volume": "26", "year": "2025" }, { "DOI": "10.1074/jbc.RA120.015924", "article-title": "ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)", "author": "Banoth", "doi-asserted-by": "publisher", "journal-title": "J Biol Chem", "key": "B90", "volume": "295", "year": "2020" }, { "DOI": "10.1084/jem.20221156", "article-title": "The Z-nucleic acid sensor ZBP1 in health and disease", "author": "Maelfait", "doi-asserted-by": "publisher", "first-page": "e20221156", "journal-title": "J Exp Med", "key": "B91", "volume": "220", "year": "2023" }, { "DOI": "10.3390/v15112141", "article-title": "ZBP1 drives IAV-induced NLRP3 inflammasome activation and lytic cell death, PANoptosis, independent of the necroptosis executioner MLKL", "author": "Malireddi", "doi-asserted-by": "publisher", "journal-title": "Viruses", "key": "B92", "volume": "15", "year": "2023" }, { "DOI": "10.1038/s41418-024-01321-6", "article-title": "ZBP1 causes inflammation by inducing RIPK3-mediated necroptosis and RIPK1 kinase activity-independent apoptosis", "author": "Koerner", "doi-asserted-by": "publisher", "journal-title": "Cell Death Differ", "key": "B93", "volume": "31", "year": "2024" }, { "DOI": "10.34133/bmr.0234", "article-title": "Targeting ZBP1-mediated PANoptosis: inflammation-responsive selenized chitosan nanoparticles loaded with moringa A for antiviral pneumonia therapy", "author": "Wu", "doi-asserted-by": "publisher", "journal-title": "Biomater Res", "key": "B94", "volume": "29", "year": "2025" }, { "DOI": "10.1016/j.cell.2020.11.025", "article-title": "Synergism of TNF-α and IFN-γ Triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes", "author": "Karki", "doi-asserted-by": "publisher", "first-page": "149", "journal-title": "Cell", "key": "B95", "volume": "184", "year": "2021" }, { "DOI": "10.1073/pnas.2500208122", "article-title": "SARS-CoV-2 infection induces ZBP1-dependent PANoptosis in bystander cells", "author": "Yang", "doi-asserted-by": "publisher", "first-page": "e2500208122", "journal-title": "Proc Natl Acad Sci U S A", "key": "B96", "volume": "122", "year": "2025" }, { "DOI": "10.3389/fcimb.2020.00237", "article-title": "Identification of the PANoptosome: A molecular platform triggering pyroptosis, apoptosis, and necroptosis (PANoptosis)", "author": "Christgen", "doi-asserted-by": "publisher", "journal-title": "Front Cell Infect Microbiol", "key": "B97", "volume": "10", "year": "2020" }, { "DOI": "10.1111/imr.12909", "article-title": "The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)", "author": "Zheng", "doi-asserted-by": "publisher", "first-page": "26", "journal-title": "Immunol Rev", "key": "B98", "volume": "297", "year": "2020" }, { "DOI": "10.3389/fimmu.2022.829433", "article-title": "Flaviviruses: innate immunity, inflammasome activation, inflammatory cell death, and cytokines", "author": "Pan", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B99", "volume": "13", "year": "2022" }, { "DOI": "10.1016/j.gene.2025.149546", "article-title": "Targeting programmed cell death pathways in gastric cancer: a focus on pyroptosis, apoptosis, necroptosis and PANoptosis", "author": "Yao", "doi-asserted-by": "publisher", "journal-title": "Gene", "key": "B100", "volume": "960", "year": "2025" }, { "DOI": "10.1016/j.coi.2023.102348", "article-title": "PANoptosome signaling and therapeutic implications in infection: central role for ZBP1 to activate the inflammasome and PANoptosis", "author": "Karki", "doi-asserted-by": "publisher", "journal-title": "Curr Opin Immunol", "key": "B101", "volume": "83", "year": "2023" }, { "DOI": "10.1016/j.tcb.2015.01.001", "article-title": "RIPK1 and RIPK3: critical regulators of inflammation and cell death", "author": "Newton", "doi-asserted-by": "publisher", "journal-title": "Trends Cell Biol", "key": "B102", "volume": "25", "year": "2015" }, { "DOI": "10.1038/nature14191", "article-title": "Necroptosis and its role in inflammation", "author": "Pasparakis", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B103", "volume": "517", "year": "2015" }, { "DOI": "10.1038/nature18629", "article-title": "Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores", "author": "Liu", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B104", "volume": "535", "year": "2016" }, { "DOI": "10.1111/imr.12541", "article-title": "Caspase-8: regulating life and death", "author": "Tummers", "doi-asserted-by": "publisher", "first-page": "76", "journal-title": "Immunol Rev", "key": "B105", "volume": "277", "year": "2017" }, { "DOI": "10.1038/s41467-020-16887-1", "article-title": "MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis", "author": "Samson", "doi-asserted-by": "publisher", "first-page": "3151", "journal-title": "Nat Commun", "key": "B106", "volume": "11", "year": "2020" }, { "DOI": "10.1038/cmi.2016.34", "article-title": "HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins", "author": "Bertheloot", "doi-asserted-by": "publisher", "first-page": "43", "journal-title": "Cell Mol Immunol", "key": "B107", "volume": "14", "year": "2017" }, { "DOI": "10.2174/1566524023666221025100002", "article-title": "Role of mitophagy in cigarette smoke-induced lung epithelial cell injury In Vitro", "author": "Wang", "doi-asserted-by": "publisher", "journal-title": "Curr Mol Med", "key": "B108", "volume": "23", "year": "2023" }, { "DOI": "10.1620/tjem.2024.J105", "article-title": "Sulforaphane inhibits LPS-induced macrophage PANoptosis via TLR4/NFκB pathway: A potential therapeutic strategy for acute lung injury", "author": "Wang", "doi-asserted-by": "publisher", "journal-title": "Tohoku J Exp Med", "key": "B109", "volume": "265", "year": "2025" }, { "DOI": "10.1016/j.celrep.2021.109858", "article-title": "ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis", "author": "Karki", "doi-asserted-by": "publisher", "journal-title": "Cell Rep", "key": "B110", "volume": "37", "year": "2021" }, { "DOI": "10.1084/jem.20191644.4", "article-title": "Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease", "author": "Malireddi", "doi-asserted-by": "publisher", "journal-title": "J Exp Med", "key": "B111", "volume": "217", "year": "2020" }, { "DOI": "10.1016/j.cytogfr.2025.09.003", "article-title": "Wiring and rewiring PANoptosis: Molecular vulnerabilities for targeting inflammatory cell death in human disease", "author": "Upmanyu", "doi-asserted-by": "publisher", "first-page": "1", "journal-title": "Cytokine Growth Factor Rev", "key": "B112", "volume": "86", "year": "2025" }, { "DOI": "10.1242/jcs.261776", "article-title": "A short guide to the tight junction", "author": "Citi", "doi-asserted-by": "publisher", "first-page": "jcs261776", "journal-title": "J Cell Sci", "key": "B113", "volume": "137", "year": "2024" }, { "DOI": "10.1242/jcs.02915", "article-title": "Myosin light chain phosphorylation regulates barrier function by remodeling tight junction structure", "author": "Shen", "doi-asserted-by": "publisher", "journal-title": "J Cell Sci", "key": "B114", "volume": "119", "year": "2006" }, { "DOI": "10.1073/pnas.2105228119", "article-title": "A dominant negative variant of RAB5B disrupts maturation of surfactant protein B and surfactant protein C", "author": "Huang", "doi-asserted-by": "publisher", "first-page": "e2105228119", "journal-title": "Proc Natl Acad Sci U S A", "key": "B115", "volume": "119", "year": "2022" }, { "DOI": "10.1007/s00018-024-05310-3", "article-title": "Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation", "author": "Hernández-Hernández", "doi-asserted-by": "publisher", "first-page": "287", "journal-title": "Cell Mol Life Sci", "key": "B116", "volume": "81", "year": "2024" }, { "DOI": "10.1063/5.0087699", "article-title": "Mechanoimmunology: Are inflammatory epigenetic states of macrophages tuned by biophysical factors", "author": "Jain", "doi-asserted-by": "publisher", "first-page": "031502", "journal-title": "APL Bioeng", "key": "B117", "volume": "6", "year": "2022" }, { "DOI": "10.1038/s41584-019-0324-5", "article-title": "Evasion of apoptosis by myofibroblasts: a hallmark of fibrotic diseases", "author": "Hinz", "doi-asserted-by": "publisher", "first-page": "11", "journal-title": "Nat Rev Rheumatol", "key": "B118", "volume": "16", "year": "2020" }, { "DOI": "10.1038/s41586-020-3014-1", "article-title": "Progenitor identification and SARS-CoV-2 infection in human distal lung organoids", "author": "Salahudeen", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B119", "volume": "588", "year": "2020" }, { "DOI": "10.1016/j.stem.2020.10.004", "article-title": "Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2", "author": "Youk", "doi-asserted-by": "publisher", "first-page": "905", "journal-title": "Cell Stem Cell", "key": "B120", "volume": "27", "year": "2020" }, { "DOI": "10.1016/j.heliyon.2023.e19601", "article-title": "Generation of 3D lung organoids from human induced pluripotent stem cells for modeling of lung development and viral infection", "author": "Tiwari", "doi-asserted-by": "publisher", "journal-title": "Heliyon", "key": "B121", "volume": "9", "year": "2023" }, { "DOI": "10.1126/science.abc1669", "article-title": "SARS-CoV-2 productively infects human gut enterocytes", "author": "Lamers", "doi-asserted-by": "publisher", "journal-title": "Science", "key": "B122", "volume": "369", "year": "2020" }, { "DOI": "10.3389/fimmu.2021.689065", "article-title": "Generation and effect testing of a SARS-CoV-2 RBD-targeted polyclonal therapeutic antibody based on a 2-D airway organoid screening system", "author": "He", "doi-asserted-by": "publisher", "journal-title": "Front Immunol", "key": "B123", "volume": "12", "year": "2021" }, { "DOI": "10.7554/eLife.66417", "article-title": "Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19", "author": "Tindle", "doi-asserted-by": "publisher", "first-page": "e66417", "journal-title": "Elife", "key": "B124", "volume": "10", "year": "2021" }, { "DOI": "10.3390/v15051166", "article-title": "Apical-out human airway organoids modeling SARS-CoV-2 infection", "author": "Chiu", "doi-asserted-by": "publisher", "journal-title": "Viruses", "key": "B125", "volume": "15", "year": "2023" }, { "DOI": "10.1038/s41586-024-07593-9", "article-title": "Author Correction: Identification of SARS-CoV-2 inhibitors using lung and colonic organoids", "author": "Han", "doi-asserted-by": "publisher", "first-page": "E7", "journal-title": "Nature", "key": "B126", "volume": "630", "year": "2024" }, { "DOI": "10.1126/science.1188302", "article-title": "Reconstituting organ-level lung functions on a chip", "author": "Huh", "doi-asserted-by": "publisher", "journal-title": "Science", "key": "B127", "volume": "328", "year": "2010" }, { "DOI": "10.1016/j.ejps.2022.106329", "article-title": "Biomimetic lung-on-a-chip to model virus infection and drug evaluation", "author": "Tan", "doi-asserted-by": "publisher", "journal-title": "Eur J Pharm Sci", "key": "B128", "volume": "180", "year": "2023" }, { "DOI": "10.1097/ms9.0000000000001887", "article-title": "Revolutionizing neurotherapeutics: blood-brain barrier-on-a-chip technologies for precise drug delivery", "author": "Kantawala", "doi-asserted-by": "publisher", "journal-title": "Ann Med Surg (Lond)", "key": "B129", "volume": "86", "year": "2024" }, { "DOI": "10.1038/s41587-020-0602-4", "article-title": "COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis", "author": "Chua", "doi-asserted-by": "publisher", "journal-title": "Nat Biotechnol", "key": "B130", "volume": "38", "year": "2020" }, { "DOI": "10.1038/s41467-020-17358-3", "article-title": "Alveolar regeneration through a Krt8+ transitional stem cell state that persists in human lung fibrosis", "author": "Strunz", "doi-asserted-by": "publisher", "first-page": "3559", "journal-title": "Nat Commun", "key": "B131", "volume": "11", "year": "2020" }, { "DOI": "10.7554/eLife.62522", "article-title": "Single-cell multiomic profiling of human lungs reveals cell-type-specific and age-dynamic control of SARS-CoV2 host genes", "author": "Wang", "doi-asserted-by": "publisher", "first-page": "e62522", "journal-title": "Elife", "key": "B132", "volume": "9", "year": "2020" }, { "DOI": "10.1038/s41586-021-03570-8", "article-title": "COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets", "author": "Delorey", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B133", "volume": "595", "year": "2021" }, { "DOI": "10.1038/s41586-021-03475-6", "article-title": "The spatial landscape of lung pathology during COVID-19 progression", "author": "Rendeiro", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B134", "volume": "593", "year": "2021" }, { "DOI": "10.1016/j.cell.2021.11.033", "article-title": "SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis", "author": "Wendisch", "doi-asserted-by": "publisher", "first-page": "6243", "journal-title": "Cell", "key": "B135", "volume": "184", "year": "2021" }, { "DOI": "10.1038/s41586-021-03493-4", "article-title": "Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV", "author": "Stukalov", "doi-asserted-by": "publisher", "journal-title": "Nature", "key": "B136", "volume": "594", "year": "2021" }, { "DOI": "10.1038/nrg2918", "article-title": "Network medicine: a network-based approach to human disease", "author": "Barabási", "doi-asserted-by": "publisher", "first-page": "56", "journal-title": "Nat Rev Genet", "key": "B137", "volume": "12", "year": "2011" }, { "DOI": "10.1038/s41467-019-09186-x", "article-title": "Network-based prediction of drug combinations", "author": "Cheng", "doi-asserted-by": "publisher", "first-page": "1197", "journal-title": "Nat Commun", "key": "B138", "volume": "10", "year": "2019" }, { "DOI": "10.1016/j.csbj.2020.03.025", "article-title": "Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model", "author": "Beck", "doi-asserted-by": "publisher", "journal-title": "Comput Struct Biotechnol J", "key": "B139", "volume": "18", "year": "2020" }, { "DOI": "10.1038/s41421-020-0153-3", "article-title": "Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2", "author": "Zhou", "doi-asserted-by": "publisher", "journal-title": "Cell Discov", "key": "B140", "volume": "6", "year": "2020" }, { "DOI": "10.1038/nchembio.1887", "article-title": "Protein degradation: Prime time for PROTACs", "author": "Deshaies", "doi-asserted-by": "publisher", "journal-title": "Nat Chem Biol", "key": "B141", "volume": "11", "year": "2015" }, { "DOI": "10.1038/s41589-019-0362-y", "article-title": "Development of targeted protein degradation therapeutics", "author": "Chamberlain", "doi-asserted-by": "publisher", "journal-title": "Nat Chem Biol", "key": "B142", "volume": "15", "year": "2019" }, { "DOI": "10.3390/microorganisms13071557", "article-title": "PROTAC-based antivirals for respiratory viruses: A novel approach for targeted therapy and vaccine development", "author": "Anugu", "doi-asserted-by": "publisher", "journal-title": "Microorganisms", "key": "B143", "volume": "13", "year": "2025" }, { "DOI": "10.1016/j.cellin.2023.100092", "article-title": "Antiviral PROTACs: Opportunity borne with challenge", "author": "Liang", "doi-asserted-by": "publisher", "journal-title": "Cell Insight", "key": "B144", "volume": "2", "year": "2023" }, { "DOI": "10.1021/acs.jmedchem.3c02416", "article-title": "Discovery of first-in-class PROTAC degraders of SARS-CoV-2 main protease", "author": "Alugubelli", "doi-asserted-by": "publisher", "journal-title": "J Med Chem", "key": "B145", "volume": "67", "year": "2024" }, { "DOI": "10.1073/pnas.2025581118", "article-title": "Network medicine framework for identifying drug repurposing opportunities for COVID-19", "author": "Morselli Gysi", "doi-asserted-by": "publisher", "first-page": "e2025581118", "journal-title": "ArXiv", "key": "B146", "volume": "118", "year": "2020" }, { "DOI": "10.1016/j.drudis.2023.103608", "article-title": "A personalized pharmaco-epistatic network model of precision medicine", "author": "Feng", "doi-asserted-by": "publisher", "journal-title": "Drug Discov Today", "key": "B147", "volume": "28", "year": "2023" }, { "DOI": "10.1056/aira2401229", "article-title": "Artificial intelligence and network medicine: path to precision medicine", "author": "Altucci", "doi-asserted-by": "publisher", "journal-title": "Nejm ai", "key": "B148", "volume": "2", "year": "2025" }, { "DOI": "10.1038/s41573-020-0090-8", "article-title": "Engineering precision nanoparticles for drug delivery", "author": "Mitchell", "doi-asserted-by": "publisher", "journal-title": "Nat Rev Drug Discov", "key": "B149", "volume": "20", "year": "2021" }, { "DOI": "10.1016/j.apsb.2021.04.023", "article-title": "Nanomedicine for acute respiratory distress syndrome: The latest application, targeting strategy, and rational design", "author": "Qiao", "doi-asserted-by": "publisher", "journal-title": "Acta Pharm Sin B", "key": "B150", "volume": "11", "year": "2021" }, { "DOI": "10.1007/s00210-025-03994-3", "article-title": "Combining computational and experimental approaches: a novel pH-responsive PVA-stabilized MXene nanocarriers/doxorubicin delivery system with enhanced efficacy for targeted lung cancer therapeutics", "author": "Fang", "doi-asserted-by": "publisher", "journal-title": "Naunyn Schmiedebergs Arch Pharmacol", "key": "B151", "volume": "398", "year": "2025" }, { "DOI": "10.1074/jbc.274.50.35434", "article-title": "Site-directed mutagenesis of diphosphoinositol polyphosphate phosphohydrolase, a dual specificity NUDT enzyme that attacks diadenosine polyphosphates and diphosphoinositol polyphosphates", "author": "Yang", "doi-asserted-by": "publisher", "journal-title": "J Biol Chem", "key": "B152", "volume": "274", "year": "1999" }, { "DOI": "10.1016/j.bbadis.2020.165808", "article-title": "Mitochondria-targeted drug delivery in cancers", "author": "Cho", "doi-asserted-by": "publisher", "journal-title": "Biochim Biophys Acta Mol Basis Dis", "key": "B153", "volume": "1866", "year": "2020" }, { "DOI": "10.1016/j.redox.2020.101799", "article-title": "Oxidative stress and diabetic retinopathy: Molecular mechanisms, pathogenetic role and therapeutic implications", "author": "Kang", "doi-asserted-by": "publisher", "journal-title": "Redox Biol", "key": "B154", "volume": "37", "year": "2020" }, { "DOI": "10.1126/science.aaa3778", "article-title": "Infectious disease. Combating emerging viral threats", "author": "Bekerman", "doi-asserted-by": "publisher", "journal-title": "Science", "key": "B155", "volume": "348", "year": "2015" }, { "DOI": "10.1016/s1473-3099(16)00078-5", "article-title": "Host-directed therapies for infectious diseases: current status, recent progress, and future prospects", "author": "Zumla", "doi-asserted-by": "publisher", "journal-title": "Lancet Infect Dis", "key": "B156", "volume": "16", "year": "2016" }, { "DOI": "10.1038/nrd.2017.162", "article-title": "Hotchkiss RS and Bartenschlager R. Host-directed therapies for bacterial and viral infections", "author": "Kaufmann", "doi-asserted-by": "publisher", "first-page": "35", "journal-title": "Nat Rev Drug Discov", "key": "B157", "volume": "17", "year": "2018" }, { "DOI": "10.1016/j.antiviral.2015.06.017", "article-title": "Towards antivirals against chikungunya virus", "author": "Abdelnabi", "doi-asserted-by": "publisher", "first-page": "59", "journal-title": "Antiviral Res", "key": "B158", "volume": "121", "year": "2015" }, { "DOI": "10.1038/s41591-018-0300-7", "article-title": "High-performance medicine: the convergence of human and artificial intelligence", "author": "Topol", "doi-asserted-by": "publisher", "first-page": "44", "journal-title": "Nat Med", "key": "B159", "volume": "25", "year": "2019" }, { "DOI": "10.1016/j.imj.2024.100130", "article-title": "Screening a neurotransmitter-receptor-related inhibitor library identifies clomipramine HCl as a potential antiviral compound against Japanese encephalitis virus", "author": "Liu", "doi-asserted-by": "publisher", "journal-title": "Infect Med (Beijing)", "key": "B160", "volume": "3", "year": "2024" } ], "reference-count": 160, "references-count": 160, "relation": {}, "resource": { "primary": { "URL": "https://www.frontiersin.org/articles/10.3389/fimmu.2026.1781447/full" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Convergent hub pathways targeted by IAV, SARS-CoV-2, and RSV in type II alveolar epithelial cells: molecular mechanisms and therapeutic implications", "type": "journal-article", "update-policy": "https://doi.org/10.3389/crossmark-policy", "volume": "17" }
Please send us corrections, updates, or comments. c19early involves the extraction of 200,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. IMA and WCH provide treatment protocols.
  or use drag and drop   
Submit